SmartVest Clearway System
Bronchiectasis, COPD, Impaired Airway Clearance
Key Facts
Indication
Bronchiectasis, COPD, Impaired Airway Clearance
Phase
Commercial
Status
Launched (2023)
Company
About Electromed
Electromed is a mission-driven, publicly traded medical device company with a 30-year history of dedicated innovation in airway clearance therapy. The company has achieved niche market leadership with its SmartVest system, demonstrating a proven strategy of U.S.-based manufacturing, direct-to-patient support via respiratory therapists, and continuous product refinement. Its core focus is on expanding access to its clinically validated HFCWO therapy to improve patient outcomes and reduce healthcare costs associated with chronic respiratory diseases.
View full company profile